Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques De Keyser

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 13, 2005
P300 after head injury: pseudodelay caused by reduced P3A amplitudeJan-Willem Elting, Joukje van der Naalt, Tiemen W van Weerden, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 12, 2009
Long-term sequelae after cerebral venous thrombosis in functionally independent patientsKaren Koopman, Maarten Uyttenboogaart, Patrick C Vroomen, et al.
ISRN Neurology|August 29, 2013
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trialJop Mostert, Thea Heersema, Manju Mahajan, et al.
Frontiers in Neurology|August 9, 2020
The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative ResultsStéphanie Hostenbach, Hubert Raeymaekers, Peter Van Schuerbeek, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
N-acetylaspartate: serum marker of reperfusion in ischemic strokeJan-Willem Elting, Geert A Sulter, Marc Langedijk, et al.
The Journal of Clinical Psychiatry|November 4, 2015
Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?Jeroen Van Schependom, Weiping Yu, Jeroen Gielen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2015
Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Miguel D'haeseleer, Stéphanie Hostenbach, Ilse Peeters, et al.
Clinical Neurology and Neurosurgery|January 12, 2008
Trismus as manifestation of bilateral internal capsule genu infarctionMarcel J H Ariës, Patrick C A J Vroomen, Johannes H van der Hoeven, et al.
Human Genetics|August 10, 2004
Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additiveMaartje Boon, Ilja M Nolte, Jacques De Keyser, et al.
Brain Injury|October 14, 2008
P300 analysis techniques in cognitive impairment after brain injury: comparison with neuropsychological and imaging dataJan Willem Elting, Natasha Maurits, Tom van Weerden, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|October 13, 2005
P300 after head injury: pseudodelay caused by reduced P3A amplitudeJan-Willem Elting, Joukje van der Naalt, Tiemen W van Weerden, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 12, 2009
Long-term sequelae after cerebral venous thrombosis in functionally independent patientsKaren Koopman, Maarten Uyttenboogaart, Patrick C Vroomen, et al.
ISRN Neurology|August 29, 2013
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trialJop Mostert, Thea Heersema, Manju Mahajan, et al.
Frontiers in Neurology|August 9, 2020
The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative ResultsStéphanie Hostenbach, Hubert Raeymaekers, Peter Van Schuerbeek, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
N-acetylaspartate: serum marker of reperfusion in ischemic strokeJan-Willem Elting, Geert A Sulter, Marc Langedijk, et al.
The Journal of Clinical Psychiatry|November 4, 2015
Do advanced statistical techniques really help in the diagnosis of the metabolic syndrome in patients treated with second-generation antipsychotics?Jeroen Van Schependom, Weiping Yu, Jeroen Gielen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2015
Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Miguel D'haeseleer, Stéphanie Hostenbach, Ilse Peeters, et al.
Clinical Neurology and Neurosurgery|January 12, 2008
Trismus as manifestation of bilateral internal capsule genu infarctionMarcel J H Ariës, Patrick C A J Vroomen, Johannes H van der Hoeven, et al.
Human Genetics|August 10, 2004
Inheritance mode of multiple sclerosis: the effect of HLA class II alleles is stronger than additiveMaartje Boon, Ilja M Nolte, Jacques De Keyser, et al.
Brain Injury|October 14, 2008
P300 analysis techniques in cognitive impairment after brain injury: comparison with neuropsychological and imaging dataJan Willem Elting, Natasha Maurits, Tom van Weerden, et al.
Pageof 18